SAMHD1 Polyclonal Antibody

SAMHD1 may play a role in regulation of the innate immune response. The SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 is upregulated in response to viral infection and may be involved in mediation of tumor necrosis factor-alpha proinflammatory responses. Mutations in this gene have been associated with Aicardi-Goutieres syndrome.

The SAMHD1 Polyclonal Antibody is a highly specific and sensitive antibody that has been designed to detect and quantify the expression of SAMHD1 protein in various biological samples. This antibody has been extensively validated for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The SAMHD1 Polyclonal Antibody is produced using high-quality materials and state-of-the-art techniques to ensure maximum specificity and sensitivity. It has been rigorously tested to ensure that it does not cross-react with other proteins, ensuring accurate and reliable results.

This antibody is suitable for use in a variety of research applications, including studies of viral replication, DNA damage response, and cell cycle regulation. It is also an excellent tool for investigating the role of SAMHD1 in various diseases, including cancer and autoimmune disorders.

Overall, the SAMHD1 Polyclonal Antibody is a valuable tool for researchers looking to study the expression and function of SAMHD1 protein in various biological systems. Its high specificity and sensitivity make it an ideal choice for a wide range of applications, and its rigorous validation ensures that it provides accurate and reliable results.